Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1988 Sep;65(1):107–112.

Short-term lymphokine stimulation of human peripheral blood mononuclear cells generates cytolytic activity against endothelial cells: involvement of natural killer cells.

A M Miltenburg 1, M E Meijer-Paape 1, M R Daha 1, L C Paul 1
PMCID: PMC1385027  PMID: 3263311

Abstract

We previously reported that incubation of human peripheral blood mononuclear cells (PBMC) for 5 days with T-cell growth factor (TCGF) resulted in lymphokine-activated killer activity against endothelial cells (EC). In this paper we report on the effects of short-term incubation of PBMC with lymphokines. We show that incubation of PBMC with lymphokines during an 18-hr period is sufficient to generate a strong cytolytic response against EC. The cytolytic capacity of the effector cells was directly dependent on the dose of lymphokine added during the induction phase. When PBMC were separated into adherent and non-adherent cells, the non-adherent fraction could be induced to lytic activity against EC, whereas the adherent cells could not. When PBMC were separated, using 2-amino-ethylisothiouronium bromide hydrobromide-treated sheep red blood cells (AET-SRBC), into T- and non-T-cell fractions, the latter fraction could be induced to lyse EC. TCGF-induced cell-mediated EC lysis could not be inhibited using anti-T3 nor anti-LFA-1 antibodies. Lysis of EC by TCGF-stimulated effector cells was strongly inhibited by the addition of unlabelled K562 target cells, whereas cold OKT3 hybridoma cells did not exert such an effect. In conclusion: the kinetics of the induction of lytic activity against EC, as well as the cell separation experiments, suggest that short-term-activated NK cells may lyse EC. This hypothesis was confirmed using monoclonal antibody and cold target cell analysis.

Full text

PDF
107

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bender J. R., Pardi R., Karasek M. A., Engleman E. G. Phenotypic and functional characterization of lymphocytes that bind human microvascular endothelial cells in vitro. Evidence for preferential binding of natural killer cells. J Clin Invest. 1987 Jun;79(6):1679–1688. doi: 10.1172/JCI113007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cines D. B., Lyss A. P., Bina M., Corkey R., Kefalides N. A., Friedman H. M. Fc and C3 receptors induced by herpes simplex virus on cultured human endothelial cells. J Clin Invest. 1982 Jan;69(1):123–128. doi: 10.1172/JCI110422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Damle N. K., Doyle L. V., Bender J. R., Bradley E. C. Interleukin 2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis. J Immunol. 1987 Mar 15;138(6):1779–1785. [PubMed] [Google Scholar]
  4. Dvorak H. F., Mihm M. C., Jr, Dvorak A. M., Barnes B. A., Manseau E. J., Galli S. J. Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response. J Exp Med. 1979 Aug 1;150(2):322–337. doi: 10.1084/jem.150.2.322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Falkoff R. M., Peters M., Fauci A. S. T cell enrichment and depletion of human peripheral blood mononuclear cell preparations. Unexpected findings in the study of the functional activities of the separated populations. J Immunol Methods. 1982;50(1):39–49. doi: 10.1016/0022-1759(82)90302-7. [DOI] [PubMed] [Google Scholar]
  6. Groenewegen G., de Ley M., Jeunhomme G. M., Buurman W. A. Supernatants of human leukocytes contain mediator, different from interferon gamma, which induces expression of MHC class II antigens. J Exp Med. 1986 Jul 1;164(1):131–143. doi: 10.1084/jem.164.1.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hancock W. W., Gee D., De Moerloose P., Rickles F. R., Ewan V. A., Atkins R. C. Immunohistological analysis of serial biopsies taken during human renal allograft rejection. Changing profile of infiltrating cells and activation of the coagulation system. Transplantation. 1985 Apr;39(4):430–438. doi: 10.1097/00007890-198504000-00018. [DOI] [PubMed] [Google Scholar]
  8. Hanto D. W., Hopt U. T., Hoffman R., Simmons R. L. Recruitment of unsensitized circulating lymphocytes to sites of allogeneic cellular interactions. Transplantation. 1982 May;33(5):541–546. doi: 10.1097/00007890-198205000-00015. [DOI] [PubMed] [Google Scholar]
  9. Henny F. C., Weening J. J., Baldwin W. M., Oljans P. J., Tanke H. J., van Es L. A., Paul L. C. Expression of HLA-DR antigens on peripheral blood T lymphocytes and renal graft tubular epithelial cells in association with rejection. Transplantation. 1986 Nov;42(5):479–483. doi: 10.1097/00007890-198611000-00007. [DOI] [PubMed] [Google Scholar]
  10. Lefkowitz M., Jorkasky D., Kornbluth J. Increase in natural killer activity in cyclosporine-treated renal allograft recipients during rejection. Hum Immunol. 1987 Jun;19(2):139–149. doi: 10.1016/0198-8859(87)90101-7. [DOI] [PubMed] [Google Scholar]
  11. Malkovský M., Loveland B., North M., Asherson G. L., Gao L., Ward P., Fiers W. Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes. Nature. 1987 Jan 15;325(6101):262–265. doi: 10.1038/325262a0. [DOI] [PubMed] [Google Scholar]
  12. Marboe C. C., Knowles D. M., 2nd, Chess L., Reemtsma K., Fenoglio J. J., Jr The immunologic and ultrastructural characterization of the cellular infiltrate in acute cardiac allograft rejection: prevalence of cells with the natural killer (NK) phenotype. Clin Immunol Immunopathol. 1983 Apr;27(1):141–151. doi: 10.1016/0090-1229(83)90063-6. [DOI] [PubMed] [Google Scholar]
  13. Miltenburg A. M., Meijer-Paape M. E., Daha M. R., Paul L. C. Endothelial cell lysis induced by lymphokine-activated human peripheral blood mononuclear cells. Eur J Immunol. 1987 Sep;17(9):1383–1386. doi: 10.1002/eji.1830170926. [DOI] [PubMed] [Google Scholar]
  14. Moreau J. F., Bonneville M., Peyrat M. A., Godard A., Jacques Y., Desgranges C., Soulillou J. P. T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis. J Clin Invest. 1986 Oct;78(4):874–879. doi: 10.1172/JCI112674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nemlander A., Saksela E., Häyry P. Are "natural killer" cells involved in allograft rejection? Eur J Immunol. 1983 Apr;13(4):348–350. doi: 10.1002/eji.1830130415. [DOI] [PubMed] [Google Scholar]
  16. Paul L. C., Baldwin W. M., 3rd, van Es L. A. Vascular endothelial alloantigens in renal transplantation. Transplantation. 1985 Aug;40(2):117–123. doi: 10.1097/00007890-198508000-00001. [DOI] [PubMed] [Google Scholar]
  17. Paul L. C., van Es L. A., van Rood J. J., van Leeuwen A., de la Rivière G. B., de Graeff J. Antibodies directed against antigens on the endothelium of peritubular capillaries in patients with rejecting renal allografts. Transplantation. 1979 Mar;27(3):175–179. doi: 10.1097/00007890-197903000-00007. [DOI] [PubMed] [Google Scholar]
  18. Phillips J. H., Lanier L. L. Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J Exp Med. 1986 Sep 1;164(3):814–825. doi: 10.1084/jem.164.3.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Robinson B. W., Morstyn G. Natural killer (NK)-resistant human lung cancer cells are lysed by recombinant interleukin-2-activated NK cells. Cell Immunol. 1987 May;106(2):215–222. doi: 10.1016/0008-8749(87)90165-1. [DOI] [PubMed] [Google Scholar]
  20. Shaw A. R., Bleackley R. C., Merryweather J. P., Barr P. J. Modulation of human natural killer cell activity by recombinant human interleukin 2. Cell Immunol. 1985 Feb;90(2):547–554. doi: 10.1016/0008-8749(85)90219-9. [DOI] [PubMed] [Google Scholar]
  21. Svedersky L. P., Shepard H. M., Spencer S. A., Shalaby M. R., Palladino M. A. Augmentation of human natural cell-mediated cytotoxicity by recombinant human interleukin 2. J Immunol. 1984 Aug;133(2):714–718. [PubMed] [Google Scholar]
  22. Trinchieri G., Matsumoto-Kobayashi M., Clark S. C., Seehra J., London L., Perussia B. Response of resting human peripheral blood natural killer cells to interleukin 2. J Exp Med. 1984 Oct 1;160(4):1147–1169. doi: 10.1084/jem.160.4.1147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Weber B., Welte M., Hammer C., Stadler J., Koller C., Caspo C., Land W., Hillebrand G., Castro M. Increase of natural killer cells in rejecting kidney grafts. Transplant Proc. 1984 Oct;16(5):1177–1178. [PubMed] [Google Scholar]
  24. Wright S. D., Rao P. E., Van Voorhis W. C., Craigmyle L. S., Iida K., Talle M. A., Westberg E. F., Goldstein G., Silverstein S. C. Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies. Proc Natl Acad Sci U S A. 1983 Sep;80(18):5699–5703. doi: 10.1073/pnas.80.18.5699. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES